Cytosorbents (CTSO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Cytosorbents (CTSO) is Moderate Underperform.

The composite score behind that read is -0.42, weighing +0.06 of bullish evidence against -0.46 bearish.

Cytosorbents last closed at $3.96, -2.22% on the session.

Against the IVW growth benchmark the position is -3.14% over the forecast window.

The read is built from 12 underlying insights — 1 bullish and 11 bearish.

Agreement across those insights is 92%.

16 graded predictions for CTSO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Cytosorbents in the 2nd percentile on return on equity, where 100 is best.

Cytosorbents is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $12.76M.

StockMap tracks Cytosorbents as the 124th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Cytosorbents ranks 123rd of 133 in the group, against a group median of -0.21.